Immunologic Research

, Volume 43, Issue 1–3, pp 172–186 | Cite as

Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures

  • Shelly J. Robertson
  • Dana N. Mitzel
  • R. Travis Taylor
  • Sonja M. Best
  • Marshall E. BloomEmail author


The tick-borne encephalitis (TBE) serocomplex of viruses, genus Flavivirus, includes a number of important human pathogens that cause serious neurological illnesses and hemorrhagic fevers. These viruses pose a significant public health problem due to high rates of morbidity and mortality, their emergence to new geographic areas, and the recent rise in the incidence of human infections. The most notable member of the TBE serocomplex is tick-borne encephalitis virus (TBEV), a neurotropic flavivirus that causes debilitating and sometimes fatal encephalitis. Although effective prophylactic anti-TBEV vaccines have been developed, there is currently no specific treatment for infection. To identify new targets for therapeutical intervention, it is imperative to understand interactions between TBEV and the host immune response to infection. Interferon (IFN) has a critical role in controlling flavivirus replication. Dendritic cells (DCs) represent an early target of TBEV infection and are major producers of IFN. Thus, interactions between DCs, IFN responses, and the virus are likely to substantially influence the outcome of infection. Early IFN and DC responses are modulated not only by the virus, but also by the tick vector and immunomodulatory compounds of tick saliva inoculated with virus into the skin. Our laboratory is examining interactions between the triad of virus, tick vector, and mammalian host that contribute to the pathogenesis of tick-borne flaviviruses. This work will provide a more detailed understanding of early events in virus infection and their impact on flavivirus pathogenesis.


Tick-borne flavivirus Ixodes tick vector Interferon antagonism Dendritic cells 



The authors thank A. Mora for graphical assistance and Drs. H. Feldmann, R. A. Heinzen, and B. Rockx for critical review of the manuscript. The authors’ research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH.


  1. 1.
    Randolph SE. Tick-borne encephalitis incidence in Central and Eastern Europe: consequences of political transition. Microbes Infect. 2008;10:209–16.PubMedCrossRefGoogle Scholar
  2. 2.
    Pugliese A, Beltramo T, Torre D. Emerging and re-emerging viral infections in Europe. Cell Biochem Funct. 2007;25:1–13.PubMedCrossRefGoogle Scholar
  3. 3.
    Zaki AM. Isolation of a flavivirus related to the tick-borne encephalitis complex from human cases in Saudi Arabia. Trans R Soc Trop Med Hyg. 1997;91:179–81.PubMedCrossRefGoogle Scholar
  4. 4.
    Heinz FX, Allison SL. Flavivirus structure and membrane fusion. Adv Virus Res. 2003;59:63–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Gritsun TS, Lashkevich VA, Gould EA. Tick-borne encephalitis. Antiviral Res. 2003;57:129–46.PubMedCrossRefGoogle Scholar
  6. 6.
    Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 2008;371:1861–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Mandl CW. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. Virus Res. 2005;111:161–74.PubMedCrossRefGoogle Scholar
  8. 8.
    Lindenbach BD, Rice CM. Molecular biology of flaviviruses. Adv Virus Res. 2003;59:23–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Murray CL, Jones CT, Rice CM. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol. 2008;6:699–708.PubMedCrossRefGoogle Scholar
  10. 10.
    Heinz FX. Molecular aspects of TBE virus research. Vaccine. 2003;21(suppl 1):S3–10.PubMedCrossRefGoogle Scholar
  11. 11.
    Best SM, et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol. 2005;79:12828–39.PubMedCrossRefGoogle Scholar
  12. 12.
    Nuttall PA, Labuda M. Dynamics of infection in tick vectors and at the tick-host interface. Adv Virus Res. 2003;60:233–72.PubMedCrossRefGoogle Scholar
  13. 13.
    Ebel GD, Kramer LD. Short report: duration of tick attachment required for transmission of powassan virus by deer ticks. Am J Trop Med Hyg. 2004;71:268–71.PubMedGoogle Scholar
  14. 14.
    Labuda M, et al. Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology. 1996;219:357–66.PubMedCrossRefGoogle Scholar
  15. 15.
    Wu SJ, et al. Human skin Langerhans cells are targets of dengue virus infection. Nat Med. 2000;6:816–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H. Visualization of Central European tick-borne encephalitis infection in fatal human cases. J Neuropathol Exp Neurol. 2005;64:506–12.PubMedGoogle Scholar
  17. 17.
    Kindberg E, et al. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis. 2008;197:266–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Glass WG, et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med. 2006;203:35–40.PubMedCrossRefGoogle Scholar
  19. 19.
    Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med. 2005;202:1087–98.PubMedCrossRefGoogle Scholar
  20. 20.
    Leonova GN. The antigenic, biological and molecular genetic characteristics of the tick-borne encephalitis virus population in the Far East. Zh Mikrobiol Epidemiol Immunobiol. 1997;5:94–7.PubMedGoogle Scholar
  21. 21.
    Mitzel DN, Best SM, Masnick MF, Porcella SF, Wolfinbarger JB, Bloom ME. Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity. Virology. 2007. doi: 10.1016/j.virol.2008.08.030.
  22. 22.
    Policastro PF, Schwan TG. Experimental infection of Ixodes scapularis larvae (Acari: Ixodidae) by immersion in low passage cultures of Borrelia burgdorferi. J Med Entomol. 2003;40:364–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Mitzel DN, Wolfinbarger JB, Long RD, Masnick M, Best SM, Bloom ME. Tick-borne flavivirus infection in Ixodes scapularis larvae: development of a novel method for synchronous viral infection of ticks. Virology. 2007;365:410–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Sonenshine DE, Hynes WL. Molecular characterization and related aspects of the innate immune response in ticks. Front Biosci. 2008;13:7046–63.PubMedCrossRefGoogle Scholar
  25. 25.
    Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801.PubMedCrossRefGoogle Scholar
  26. 26.
    Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7:131–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Honda K, et al. Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA. 2003;100:10872–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Honda K, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434:772–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Diamond MS, Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology. 2001;289:297–311.PubMedCrossRefGoogle Scholar
  30. 30.
    Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol. 2000;74:4957–66.PubMedCrossRefGoogle Scholar
  31. 31.
    Lin RJ, Liao CL, Lin E, Lin YL. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol. 2004;78:9285–94.PubMedCrossRefGoogle Scholar
  32. 32.
    Brinton MA, Perelygin AA. Genetic resistance to flaviviruses. Adv Virus Res. 2003;60:43–85.PubMedCrossRefGoogle Scholar
  33. 33.
    Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA. Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA. 2002;99:9322–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Sadler AJ, Williams BR. Structure and function of the protein kinase R. Curr Top Microbiol Immunol. 2007;316:253–92.PubMedCrossRefGoogle Scholar
  35. 35.
    Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005;5:375–86.PubMedCrossRefGoogle Scholar
  36. 36.
    Ihle JN. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol. 1995;60:1–35.PubMedCrossRefGoogle Scholar
  37. 37.
    Chang TH, Liao CL, Lin YL. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3 K-dependent NF-kappaB activation. Microbes Infect. 2006;8:157–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Gilfoy FD, Mason PW. West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J Virol. 2007;81:11148–58.PubMedCrossRefGoogle Scholar
  39. 39.
    Kato H, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006;441:101–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Fredericksen BL, Gale M Jr. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol. 2006;80:2913–23.PubMedCrossRefGoogle Scholar
  41. 41.
    Best SM, Mitzel DN, Bloom ME. Action and reaction: the arthropod-borne flaviviruses and host interferon responses. Future Virol. 2006;1:447–59.CrossRefGoogle Scholar
  42. 42.
    Guo JT, Hayashi J, Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol. 2005;79:1343–50.PubMedCrossRefGoogle Scholar
  43. 43.
    Ho LJ, et al. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol. 2005;174:8163–72.PubMedGoogle Scholar
  44. 44.
    Jones M, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol. 2005;79:5414–20.PubMedCrossRefGoogle Scholar
  45. 45.
    Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL. Blocking of interferon-induced Jak- Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol. 2006;80:5908–18.PubMedCrossRefGoogle Scholar
  46. 46.
    Werme K, Wigerius M, Johansson M. Tick-borne encephalitis virus NS5 associates with membrane protein scribble and impairs interferon-stimulated JAK-STAT signalling. Cell Microbiol. 2008;10:696–712.PubMedCrossRefGoogle Scholar
  47. 47.
    Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA. 2003;100:14333–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Munoz-Jordan JL, et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol. 2005;79:8004–13.PubMedCrossRefGoogle Scholar
  49. 49.
    Park GS, Morris KL, Hallett RG, Bloom ME, Best SM. Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain. J Virol. 2007;81:6936–46.PubMedCrossRefGoogle Scholar
  50. 50.
    Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol. 2001;75:3501–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Martina BE, Koraka P, van den Doel P, Rimmelzwaan GF, Haagmans BL, Osterhaus AD. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha. Virus Res. 2008;135:64–71.PubMedCrossRefGoogle Scholar
  52. 52.
    Silva MC, Guerrero-Plata A, Gilfoy FD, Garofalo RP, Mason PW. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol. 2007;81:13640–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Ueno H, et al. Dendritic cell subsets in health and disease. Immunol Rev. 2007;219:118–42.PubMedCrossRefGoogle Scholar
  54. 54.
    Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol. 2007;7:543–55.PubMedCrossRefGoogle Scholar
  55. 55.
    Masson F, Mount AM, Wilson NS, Belz GT. Dendritic cells: driving the differentiation programme of T-cells in viral infections. Immunol Cell Biol. 2008;86:333–42.PubMedCrossRefGoogle Scholar
  56. 56.
    Palmer DR, et al. Differential effects of dengue virus on infected and bystander dendritic cells. J Virol. 2005;79:2432–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Sanchez V, Hessler C, DeMonfort A, Lang J, Guy B. Comparison by flow cytometry of immune changes induced in human monocyte-derived dendritic cells upon infection with dengue 2 live-attenuated vaccine or 16681 parental strain. FEMS Immunol Med Microbiol. 2006;46:113–23.PubMedCrossRefGoogle Scholar
  58. 58.
    Belkaid Y. Regulatory T-cells and infection: a dangerous necessity. Nat Rev Immunol. 2007;7:875–88.PubMedCrossRefGoogle Scholar
  59. 59.
    Luhn K, et al. Increased frequencies of CD4+CD25(high) regulatory T-cells in acute dengue infection. J Exp Med. 2007;204:979–85.PubMedCrossRefGoogle Scholar
  60. 60.
    Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol. 2002;14:432–6.PubMedCrossRefGoogle Scholar
  61. 61.
    Lopez CB, Garcia-Sastre A, Williams BR, Moran TM. Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis. 2003;187:1126–36.PubMedCrossRefGoogle Scholar
  62. 62.
    Munir S, Le Nouen C, Luongo C, Buchholz UJ, Collins PL, Bukreyev A. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J Virol. 2008;82:8780–96.PubMedCrossRefGoogle Scholar
  63. 63.
    Rudd BD, Luker GD, Luker KE, Peebles RS, Lukacs NW. Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol. 2007;20:531–40.PubMedCrossRefGoogle Scholar
  64. 64.
    Gillespie RD, Mbow ML, Titus RG. The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol. 2000;22:319–31.PubMedCrossRefGoogle Scholar
  65. 65.
    Wikel SK. Tick modulation of host immunity: an important factor in pathogen transmission. Int J Parasitol. 1999;29:851–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Deruaz M, et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med. 2008;205:2019–31.PubMedCrossRefGoogle Scholar
  67. 67.
    Skallova A, Iezzi G, Ampenberger F, Kopf M, Kopecky J. Tick saliva inhibits dendritic cell migration, maturation, and function while promoting development of Th2 responses. J Immunol. 2008;180:6186–92.PubMedGoogle Scholar
  68. 68.
    Pierson TC, Fremont DH, Kuhn RJ, Diamond MS. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe. 2008;4:229–38.PubMedCrossRefGoogle Scholar
  69. 69.
    Kaiser R, Holzmann H. Laboratory findings in tick-borne encephalitis—correlation with clinical outcome. Infection. 2000;28:78–84.PubMedCrossRefGoogle Scholar
  70. 70.
    King NJ, Getts DR, Getts MT, Rana S, Shrestha B, Kesson AM. Immunopathology of flavivirus infections. Immunol Cell Biol. 2007;85:33–42.PubMedCrossRefGoogle Scholar
  71. 71.
    Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol. 2006;80:9349–60.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Shelly J. Robertson
    • 1
  • Dana N. Mitzel
    • 1
  • R. Travis Taylor
    • 1
  • Sonja M. Best
    • 1
  • Marshall E. Bloom
    • 1
    Email author
  1. 1.Laboratory of Virology, Rocky Mountain LaboratoriesNational Institute of Allergy and Infectious Diseases, National Institutes of HealthHamiltonUSA

Personalised recommendations